HY1272
/ Newsoara Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 23, 2024
HY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLC
(clinicaltrials.gov)
- P1 | N=40 | Not yet recruiting | Sponsor: Newsoara Biopharma Co., Ltd.
Metastases • New P1 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1